 |
Autologous human peripheral blood Vdelta1+ T lymphocytes activated in vitro by cytokine and monoclonal antibody treatment |
|---|---|
| Trade Name | |
| Orphan Indication | small lymphocytic lymphoma |
| EU Market Approval | EU |
| EU Designation Date | 2015-10-09 00:00:00 |
| Sponsor | Lymphact - Lymphocyte Activation Technologies S.A. |
